Mereo BioPharma Group (MREO) News Today → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free MREO Stock Alerts $3.27 +0.07 (+2.19%) (As of 01:57 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 4:12 AM | americanbankingnews.comMereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Needham & Company LLCMay 20 at 2:50 AM | americanbankingnews.comFY2024 EPS Estimates for Mereo BioPharma Group plc Decreased by Analyst (NASDAQ:MREO)May 20 at 2:50 AM | marketbeat.comFY2024 Earnings Estimate for Mereo BioPharma Group plc (NASDAQ:MREO) Issued By Cantor FitzgeraldMereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Research analysts at Cantor Fitzgerald cut their FY2024 earnings estimates for shares of Mereo BioPharma Group in a note issued to investors on Thursday, May 16th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will posMay 20 at 1:38 AM | americanbankingnews.comEquities Analysts Offer Predictions for Mereo BioPharma Group plc's Q2 2024 Earnings (NASDAQ:MREO)May 18 at 5:36 AM | americanbankingnews.comCantor Fitzgerald Reiterates "Overweight" Rating for Mereo BioPharma Group (NASDAQ:MREO)May 18 at 4:44 AM | americanbankingnews.comLeerink Partnrs Comments on Mereo BioPharma Group plc's FY2024 Earnings (NASDAQ:MREO)May 17 at 8:44 AM | marketbeat.comFY2024 EPS Estimates for Mereo BioPharma Group plc Raised by Leerink Partnrs (NASDAQ:MREO)Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Leerink Partnrs increased their FY2024 earnings estimates for shares of Mereo BioPharma Group in a report released on Wednesday, May 15th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings of $0.12 per sMay 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and PAVmed (PAVM)May 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $7.00 target price on shares of Mereo BioPharma Group in a research note on Thursday.May 16, 2024 | finanznachrichten.deMereo BioPharma Group plc: Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | globenewswire.comMereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 1, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday TradingMay 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Mereo Biopharma Group Plc (MREO) and Arcus Biosciences (RCUS)May 1, 2024 | markets.businessinsider.comStrong Buy Rating for Mereo Biopharma on Setrusumab’s Promising Phase 3 Progress and Financial OutlookApril 29, 2024 | marketbeat.comabrdn plc Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)abrdn plc purchased a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,551,082 shares of the company's stock, valued at approximately $3,583,000. abrApril 3, 2024 | globenewswire.comMereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 28, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and issued a $7.00 price objective on shares of Mereo BioPharma Group in a research report on Thursday.March 28, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Price Target Raised to $6.00Needham & Company LLC increased their price objective on Mereo BioPharma Group from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Thursday.March 27, 2024 | globenewswire.comMereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 22, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $7.00 target price on shares of Mereo BioPharma Group in a report on Friday.March 16, 2024 | finance.yahoo.comMREO Apr 2024 3.500 putMarch 16, 2024 | ca.finance.yahoo.comMREO Aug 2024 5.500 callMarch 16, 2024 | finance.yahoo.comMREO Apr 2024 1.500 callMarch 16, 2024 | finance.yahoo.comMREO Apr 2024 3.000 putMarch 14, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Short Interest Down 19.8% in FebruaryMereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) saw a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 2,230,000 shares, a decline of 19.8% from the February 14th total of 2,780,000 shares. Based on an average daily volume of 1,590,000 shares, the short-interest ratio is presently 1.4 days.March 13, 2024 | seekingalpha.comVoyager Therapeutics gets new chief medical officerMarch 12, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Purchases Shares of 800,000 Mereo BioPharma Group plc (NASDAQ:MREO)Adage Capital Partners GP L.L.C. purchased a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 800,000 shares of the company'sMarch 5, 2024 | globenewswire.comMereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceMarch 1, 2024 | marketbeat.com683 Capital Management LLC Purchases 600,000 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)683 Capital Management LLC grew its stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 11.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,000,000 shares of the company's sFebruary 23, 2024 | finance.yahoo.comMereo BioPharma Group plc (MREO)February 16, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Shares Acquired by Tejara Capital LtdTejara Capital Ltd raised its stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 5.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,215,001 shares of the company's stock after acquiring anFebruary 14, 2024 | marketbeat.comFormidable Asset Management LLC Acquires New Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)Formidable Asset Management LLC bought a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 331,914 shares of the company's stock, valued at approximately $428,February 9, 2024 | marketbeat.comMereo BioPharma Group plc to Post FY2023 Earnings of ($0.04) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:MREO)Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2023 EPS estimates for Mereo BioPharma Group in a research note issued on Wednesday, February 7th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earningsFebruary 5, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $4.36Mereo BioPharma Group (NASDAQ:MREO) Sets New 1-Year High at $4.36January 31, 2024 | finance.yahoo.comAM Best Assigns Preliminary Credit Assessment to Mereo Insurance LimitedJanuary 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)December 29, 2023 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Short Interest UpdateMereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 1,810,000 shares, a drop of 33.9% from the November 30th total of 2,740,000 shares. Based on an average daily trading volume, of 1,281,200 shares, the days-to-cover ratio is currently 1.4 days.December 20, 2023 | benzinga.comMereo BioPharma Group Stock (NASDAQ:MREO) Dividends: History, Yield and DatesDecember 19, 2023 | finance.yahoo.comHedge Funds Say These Penny Stocks Are Poised to ExplodeNovember 3, 2023 | finance.yahoo.comUltragenyx (RARE) Q3 Earnings and Revenues Miss EstimatesOctober 25, 2023 | finanznachrichten.deMereo BioPharma Group plc: Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateOctober 25, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO)October 16, 2023 | benzinga.comWhy Is Mereo BioPharma Stock Trading Higher Today?October 14, 2023 | finance.yahoo.comUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)September 27, 2023 | finance.yahoo.comMREO Oct 2023 2.500 putSeptember 9, 2023 | msn.comCantor Fitzgerald Reiterates Mereo Biopharma Group Plc - ADR (MREO) Overweight RecommendationSeptember 8, 2023 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Issues Earnings Results, Hits EstimatesMereo BioPharma Group (NASDAQ:MREO - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02).September 7, 2023 | finance.yahoo.comMereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate UpdateAugust 19, 2023 | fool.comMereo BioPharma Group Plc (NASDAQ: MREO)August 11, 2023 | finance.yahoo.comBAKER BROS. ADVISORS LP Acquires Significant Stake in Mereo BioPharma Group PLC Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. MREO Media Mentions By Week MREO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.480.42▲Average Medical News Sentiment MREO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼191▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ESPR News Today HRTX News Today NGNE News Today STTK News Today VRCA News Today KRRO News Today ANNX News Today BMEA News Today TERN News Today ANRO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestObama’s Forever Term [exposed]Porter & CompanyNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
